https://oncopeptides.com/press-releases/oncopeptides-and-vector-pharma-fzco-announce-collaboration-to-provide-pepaxti-to-patients-in-the-middle-east-and-north-africa/
Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the...
Stockholm, Sweden and Dubai, UAE, March 27, 2024 – Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Vector Pharma FZCO...
in theoncopeptidesvectorpharmaannounce
https://oncopeptides.com/oncopeptalks/oncopeptalks-congresses-and-cd-selection/
Oncopeptalks - Congresses and CD selection - Oncopeptides
congressesselectiononcopeptides
https://www.healthcap.eu/media/oncopeptides-publishes-the-2020-annual-report/
Oncopeptides publishes the 2020 Annual Report - HealthCap
STOCKHOLM — April 26, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for...
annual reportoncopeptidespublisheshealthcap
https://oncopeptides.com/sv/pressmeddelanden/oncopeptides-avser-lamna-in-en-typ-ii-variation-for-att-expandera-pepaxtis-indikation-till-behandling-i-tredje-linjen/
Oncopeptides avser lämna in en typ II-variation för att expandera Pepaxtis indikation till...
STOCKHOLM — 11 maj 2026 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), ett biotechbolag fokuserat på svårbehandlade cancersjukdomar, meddelar idag sin...
oncopeptidesavsertypvariationatt
https://www.healthcap.eu/media/oncopeptides-publishes-report-for-q1-2021-and-updated-dates-for-the-publication-of-the-reports-for-q2-and-q3-2021/
Oncopeptides publishes report for Q1 2021 and updated dates for the publication of the reports for...
A strong start for PEPAXTO in the US STOCKHOLM — May 26, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the...
oncopeptidespublishesreportupdateddates
https://medicalupdateonline.com/tag/oncopeptides-ab/
Oncopeptides AB Archives - Medical Update Online
oncopeptidesarchivesmedicalupdateonline